Share this post on:

Product Name :
Misoprostol

Search keywords :
EP2

drugId :
null

Target Vo:
Prostanoid EP2 receptor

Target Vo Short Name :
PTGER2

Moa_Name:
Prostanoid EP2 receptor agonists

First Approval Country :
Switzerland

First Approval Date Filter:
1984

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Ain Shams University

Active Indication_Name:
Terminate pregnancy

In Active Indication_Name:
Cystitis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CDC37 Antibody Epigenetics
ATG10 Antibody supplier
phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody: phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody is an unconjugated, approximately 124 kDa, rabbit-derived, anti-phospho-LATS1+LATS2 (Thr1079 +Thr1041) polyclonal antibody. phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.

Share this post on:

Author: Betaine hydrochloride